Product Information
MEPROBAMATE 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $4.6653 per EA under NDC 69097097407. Its NADAC has been published 102 times since Jul 17, 2024.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097097407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEPROBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA040797On Market Since
6/7/2021
Price Statistics
The NADAC for MEPROBAMATE 200 MG TABLET has been published 102 times since Jul 17, 2024, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6653 per EA |
|---|---|
| All-time high | $5.0893 (Mar 11, 2026) |
| All-time low | $3.9537 (Apr 23, 2025) |
| 52-week high | $5.0893 |
| 52-week low | $3.9537 |
| Median price | $4.1896 |
| Average price | $4.4083 |
| Largest weekly change | +28.7% (Feb 18, 2026) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEPROBAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEPROBAMATE 200 MG TABLET, manufactured by Cipla USA Inc., is $4.6653 per EA (NDC 69097097407), effective Jun 24, 2026.
How has the price of MEPROBAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEPROBAMATE 200 MG TABLET has declined 6.9%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for MEPROBAMATE 200 MG TABLET?
Since Jul 17, 2024, the NADAC for MEPROBAMATE 200 MG TABLET has ranged from a low of $3.9537 (Apr 23, 2025) to a high of $5.0893 (Mar 11, 2026), with a median of $4.1896 per EA.
Are there cheaper alternatives to MEPROBAMATE 200 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEPROBAMATE 200 MG TABLET, but none are currently priced below it.
Who manufactures MEPROBAMATE 200 MG TABLET?
MEPROBAMATE 200 MG TABLET (NDC 69097097407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification